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DNA complementary to the rat hypothalamic mRNA coding for the corticotropin-releasing factor precur- 
sor (prepro-CRF) has been cloned by screening a cDNA library with a human genomic DNA probe. Nu- 
cleotide sequence analysis of the cloned cDNA has revealed that rat prepro-CRF consists of 187 amino 
acid residues including a putative signal pcptide. The CRF and putative signal peptide regions are more 
highly conserved among rat, human and ovine prcpro-CRF than is the cryptic portion. 
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1. INTRODUCTION 
The primary structures of the biosynthetic 
precursors of ovine and human CRF have previous- 
ly been elucidated by cloning and sequencing the 
cDNA and the genomic DNA, respectively [ 1,2]. 
The deduced structure of human CRF exhibits 7 
amino acid substitutions in comparison with ovine 
CRF [3], but is identical with the structure of rat 
CRF [4]. In view of the fact that the rat has been 
used most frequently in studies on the control of 
the hypothalamo-pituitary-adrenocortical system, 
we have now cloned and sequenced cDNA for the 
rat prepro-CRF. 
and poly(A)+ RNA was isolated by oligo(dT)- 
cellulose chromatography as in [I]. A cDNA 
library was constructed with 4 pg of this poly(A)+ 
RNA and 1.5 pg vector-primer DNA according to 
[5]. Escherichia coli x1776 or HBlOl was used for 
transformation as in [ 11. Ampicillin-resistant 
transformants were screened as in [6] by hybridiza- 
tion at 55°C with the 446 bp &a1 fragment com- 
prising nucleotide residues 215-660 of the human 
prepro-CRF gene [2]; the probe was labelled with 
[u-32P]dCTP by nick-translation [7]. DNA se- 
quencing was carried out by the procedure in [S]. 
Reagents were obtained as in [9]. 
3. RESULTS AND DISCUSSION 
2. MATERIALS AND METHODS 
Total RNA was extracted from rat hypothalami, 
Abbreviations: CRF, corticotropin-releasing factor; 
prepro-CRF, corticotropin-releasing factor precursor 
’ To whom correspondence should be addressed 
A cDNA library derived from rat hypothalamic 
poly(A)+ RNA was screened with a human genomic 
DNA probe. From about 1.4 x lo6 transformants, 
5 hybridization-positive clones were isolated. One 
of them (clone prCRF87), which apparently carried 
the largest cDNA insert, was subjected to restric- 
tion mapping and nucleotide sequence analysis. 
Dedicated to Professor Karl Decker on the occasion of Fig.1 shows the nucleotide sequence of the 
his 60th birthday mRNA coding for rat prepro-CRF, deduced from 
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5'----AAACUCAGAGCCCAAGUACGUUGAGAAACUGAAGAGAAAGGGGAAAGGCAAAGAAAAGGAGAAGAGAPAGGAGAAGAGGAAGAAAACCUGCAGGAGGCAUCCUGAGAGAGGUAC 
-1io -ii0 -150 -lb0 -tYO -6.0 
Mk Arg Leu Arg Leu Leu Val Ser Ala Git Met Leu Leu Val Ala 
CUCGCAGAACAACAGUGCGGGCUCACCUGCCAAGGGAGGAGAAGAGAGCGCCCC['AAAC AUG CGG CUG CGG CUG CUG GUG UCC GCG GGC AUG CUG CUG GUG GCU 
-do -2.0 -i i i0 40 
L'eu Set- Pro Cys L% Pro Cys Arg Ala Leu Leu Ser Arg Gly STr Val Ser Gly Ala Pro Arg Ala Pro Gln P$ Leu Asn Phe Leu Gln 
CUG UCG CCC UGU CUG CCU UGC AGG GCC CUG CUG AGC AGC GGA UCC GUC UCU GGA GCG CCG CGG GCC CCG CAG CCG UUG AAU UUC UUG CAA 
6'0 fi0 100 150 
50 60 70 
Pro Glu Gln Pro Gln Gin Pro Gln Pro Ile Leu Ile Arg Met Gly Glu Glu Tyr Phe Leu Arg Leu Gly Asn Leu Asn Arg Ser Pro Ala 
CCG GAG CAG CCC CAG CAA CCU CAG CCG AUU CUG AUC CGC AUG GGU GAA GAA UAC UUC CUC CGC CUG GGG AAC CUC AAC AGA AGU CCC GCU 
ii0 l&O 160 260 2io 
Ala Arg Leu Ser P",", Asn Ser Thr Pro LPU T 
90 100 
,hr Ala Gly Arg Gly Ser Arg Pro Ser His Asp Gln Ala Ala Ala Asn Phe Phe Arg Val 
GCU CGG CUG UCC CCC AAC UCC ACG CCC CUC ACC GCG GGU CGC GGC AGC CGC CCC UCG CAC GAC CAG GCU GCG GCU AAC UUU UUC CGC GUG 
240 2io 2tio 360 
110 120 130 
Leu Leu Gln Gln Leu Gin Met Pro Gin Arg Pro Leu Asp Ser Ser Thr Glu Leu Ala Glu Arg Gly Ala Glu Asp Ala Leu Gly Gly His 
UUG CUG CAG CAG CUG CAG AUG CCU CAG CGC CCG CUC GAC AGC AGC ACG GAG CUG GCG GAA CGC GGC GCC GAG GAU GCC CUC GGU GGC CAC 
350 3io 360 3io 460 
140 150 160 
Gln Gly Ala Leu Glu Arg Glu Arg Arg Ser Glu Glu Pro Pro Ile Ser Leu Asp LeuThrPhFfis Leu Leu Arg Glu Val Leu Glu Met 
r 
_~ 
CAG GGG GCG CUG GAG AGG GAG AGG CGG U<C GAG GAG C$G 
4io 
CcC_AUC UCU CUG GAU c_UCmACC U_UC_ C&@U_CllG AGG GAA GUC UUG~GAA AUG _- ..- 
440 460 480 
170 180 
Ala Arg Ala Glu G~~&Alaln~Ala His Ser Asn Arg Lys Leu Met Glu Ile Ild Gly Lys 
m AGG GCA GAG CAG UUAU CAG CAA GCU_CA&AGC AAC_AGG AAA CUG AUG GAG AUU AUC( GGG AJA UGA AAUGUUGCGCUUGGCCAAAACGAUUCUG 
5% 
--p 
500 540 5fio 580 
CAUUUAGCACACAAGUAAAAAUAAAAAAUUUAAAACACAGUAUUCUGUACCAUACUGCAGCUCUGAUA~~CAUUUGUUUAUUUUUAUAUAGCUUGAAGCAUAGAAGAU~UACAGGGAGAGA 
660 650 640 660 GO 700 
GCCUAUAUACCCCUUAAUUAGCAUGCACAAAGUGUGUUUCUUUGUAGUAACAAAACAGCGUUAUUUGUAUUGUUCACGCUUAGUUUCUAUGUGCAAAUAAGUGUCU~'JAUAGCGAUAUCU 
750 7io Go 7Ao 860 f3iO 
UAAAGAAAAUGUGGAUCCAAGGAGGAAACCUUUAAAAAAGCAGAUGGAAGUCACCCAGUUGUUUUUAU~IUGGA~ACACAGUGUAAGAGAAUUCAUUCUUGAGGGGUGGCUAGGACAAAAU 
eio SiO GO 900 9io 9io 
GUGUAAGCUCUUUGAAUCAACUUUUUCUUGUAAAUGUUUC~UAA~AAAACAUCUUUCUGAUCCUUGGUC----3' 
9io 980 1600 IO.20 
Fig. 1. Primary structure of rat prepro-CRF mRNA. Nucleotide residues are numbered in the 5 ’ - to 3 ‘-direction, begin- 
ning with the first residue of the AUG triplet encoding the initiating methionine, and the nucleotides on the 5’-side of 
residue 1 are indicated by negative numbers. The 3’-terminal sequence shown is followed by a poly(A) tract. Amino 
acid residues are numbered beginning with the initiating methionine. The CRF sequence, together with the coding 
nucleotides, is boxed. 
the cDNA sequence. Because the 5’-end of the 
cDNA sequence corresponds to the position 2 
nucleotides downstream of the putative capping 
site of the human prepro-CRF gene [2], it is as- 
sumed that clone prCRF87 carries an almost full- 
length cDNA sequence. This is also supported by 
the size of the mRNA (approx. 1300 nucleotides) 
estimated by blot hybridization analysis of rat 
hypothalamic poly(A)+ RNA [lo]. The 3 ’ -untrans- 
lated region of the mRNA contains 2 copies of the 
polyadenylation signal AAUAAA [ 1 l] (residues 
612-617 and 996-lOOl), one of which is located 22 
nucleotides upstream of the poly(A) tract. 
The primary structure of rat prepro-CRF was 
deduced by using the reading frame of the mRNA 
64 
corresponding to the known amino acid sequences 
of the ovine and human counterparts [1,2] (fig. 1). 
The translational initiation site assigned is cor- 
roborated by the finding that this site represents 
the first AUG triplet that appears downstream of 
a nonsense codon (UGA at positions - 144 to 
- 142) found in frame. The sequence of the 24 
amino acid residues starting with the initiating 
methionine exhibits a feature characteristic of the 
signal peptide of secretory proteins [12,13]. A 
possible site for cleavage of the signal peptide 
seems to be located after the alanine residue 
specified by the 24th codon (alternatively after the 
serine residue specified by the 27th codon). A 
translational termination codon (UGA) is found in 
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Fig.2. Alignment of the amino acid sequences of rat (top), human (middle) and ovine (bottom) prepro-CRF. The one- 
letter amino acid notation is used. The human and ovine sequences have been taken from [2] and [ 11, respectively. Sets 
of identical residues are enclosed with solid lines, and sets of conservative residues with dashed lines. Conservative 
amino acid substitutions are defined as pairs of residues belonging to one of the following groups: S, T, P, A and G; 
N, D, E and Q; H, R and K; M, 1, L and V; F, Y and W (161. Gaps (-) have been inserted to achieve maximum 
homology. The positions in the aligned sequences including gaps are numbered beginning with that of the initiating 
methionine. 
frame after the 187th codon specifying lysine. 
Thus, it is concluded that rat prepro-CRF consists 
of 187 amino acid residues including a putative 
signal peptide. 
The deduced sequence of amino acid residues 
145-185 agrees precisely with the sequence of rat 
CRF determined by peptide analysis [4]. The se- 
quence of rat CRF in the precursor, like its ovine 
and human counterparts [1,2], is preceded by the 
paired basic residues Arg-Arg, which apparently 
represent the site of proteolytic processing [ 131, 
and is followed by the dipeptide Gly-Lys, which 
constitutes the carboxyl-end of the precursor. This 
implies that the carboxy-terminal isoleucine residue 
of rat CRF is also amidated (e.g., see [ 14,151). The 
cryptic portion of ovine and human prepro-CRF 
contains an additional pair of basic residues (Arg- 
Arg) at an equivalent position (aligned positions 
123 and 124 in fig.2). In rat prepro-CRF, this 
dibasic structure is replaced by Gin-Arg. 
The alignment of the amino acid sequences of 
rat, human and ovine prepro-CRF is shown in 
fig.2. The degrees of sequence homology between 
the whole precursors are 80, 65 and 76% for the 
rat/human, rat/ovine and human/ovine pairs, 
respectively; gaps have been counted as one sub- 
stitution regardless of their length. The CRF 
region (83-100%) and the putative signal peptide 
region (75-92%) are more highly conserved among 
the 3 species than is the cryptic portion corre- 
sponding to aligned positions 25- 152 (55-72%), 
where several amino acid deletions (or insertions) 
occur. 
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